U.S. Markets close in 3 hrs, 9 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,173.43 | 150.01 | 1.50% |
| NASDAQ | 2,143.54 | 31.10 | 1.47% |
| S&P 500 | 1,086.49 | 17.19 | 1.61% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -2.78 | Current P/E Ratio: | -4.39568 |
|---|---|---|---|
| Last Quarter's Earnings: | 0.80 | Current Quarter Estimate: | -0.514 |
| Last Fiscal Year Earnings: | -3.58 | Next Fiscal Year Estimate: | -1.757 |
| Analyst Consensus: | Strong Buy | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Strong Buy
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 02/01/2010 * | 18:00 | Q4 2009 MAP Pharmaceuticals, Inc. Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/05/2009 | Q3 2009 MAP PHARMACEUTICALS INC Earnings Release | — | — |
| 09/14/2009 | MAP PHARMACEUTICALS INC at Morgan Stanley Global Healthcare Conference |  |
— |
| 09/11/2009 | MAP PHARMACEUTICALS INC at Thomas Weisel Partners Healthcare Conference | — | — |
| 08/03/2009 | Q2 2009 MAP PHARMACEUTICALS INC Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts